Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase-I Study of Radiolabeled DFH-12 (PulmoBind) for Molecular Imaging of the Pulmonary Circulation

NCT01539889 is registered in ClinicalTrials.gov with Montreal Heart Institute as lead sponsor.

NCT NCT01539889
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01539889 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase-I Study of Radiolabeled DFH-12 (PulmoBind) for Molecular Imaging of the Pulmonary Circulation
Lead sponsor
Montreal Heart Institute
Phase
Phase 1
Overall status
Completed
Start date
December 31, 2011
Completion date
January 31, 2013
Enrollment
20 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

pulmonary disease, pulmonary hypertension